A detailed history of Blue Crest Capital Management LTD transactions in Vaccitech PLC stock. As of the latest transaction made, Blue Crest Capital Management LTD holds 542,673 shares of VACC stock, worth $1.85 Million. This represents 0.11% of its overall portfolio holdings.

Number of Shares
542,673
Previous 542,673 -0.0%
Holding current value
$1.85 Million
Previous $1.85 Million -0.0%
% of portfolio
0.11%
Previous 0.11%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 16, 2022

SELL
$4.51 - $11.75 $1,804 - $4,700
-400 Reduced 0.07%
542,673 $2.82 Million
Q4 2021

Feb 14, 2022

BUY
$8.98 - $15.55 $4.88 Million - $8.44 Million
543,073 New
543,073 $6.03 Million

Others Institutions Holding VACC

About Vaccitech plc


  • Ticker VACC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 37,216,200
  • Market Cap $127M
  • Description
  • Vaccitech plc, a clinical-stage biopharmaceutical company, engages in the discovery and development of novel T cell immunotherapeutics and vaccines for the treatment and prevention of infectious diseases and cancers. The company's therapeutic programs include VTP-300, which is in Phase 1/2a clinical trial for the treatment of chronic hepatitis B...
More about VACC
Track This Portfolio

Track Blue Crest Capital Management LTD Portfolio

Follow Blue Crest Capital Management LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Blue Crest Capital Management LTD, based on Form 13F filings with the SEC.

News

Stay updated on Blue Crest Capital Management LTD with notifications on news.